|
Real-time
Euronext Paris
07:41:55 2026-10-02 EDT
|
5-day change | 1st Jan Change | ||
| 0.8340 EUR | -0.48% |
|
-10.32% | +39.93% |
| 09-04 | Biosynex: creditors to vote on financial safeguard plan | |
| 08-06 | Biosynex hit by cyberattack, operational activity remains intact |
Business description: Biosynex

- manufacturing of diagnosis tests for own account;
- sale of diagnosis tests supplied by other manufacturers of semi-finished products;
- research and development services for third party;
- sale of licenses;
- sale of biological reagents.
Number of employees: 397
Sales by Activity: Biosynex
| Fiscal Period: December | 2021 (EUR) | 2022 (EUR) | 2023 (EUR) | 2024 (EUR) | 2025 (EUR) |
|---|---|---|---|---|---|
Sale of Merchandise | 175M | 99.36M | 52.09M | 42.94M | 39.47M |
Products Sold | 44.06M | 29.86M | 15.39M | 24.63M | 25.21M |
Services Sold | 18.58M | 9.39M | 2.37M | 1.89M | 1.52M |
Unallocated Immobilised Production | 525K | 672K | 1.35M | 911K | 528K |
Unallocated Operating Grants | 436K | 282K | - | - | - |
Geographical breakdown of sales: Biosynex
| Fiscal Period: December | 2021 (EUR) | 2022 (EUR) | 2023 (EUR) | 2024 (EUR) | 2025 (EUR) |
|---|---|---|---|---|---|
France | 194M | 120M | 52.5M | 52.82M | 49.26M |
Export | 189M | 76.4M | 40.4M | 48.35M | 45.93M |
Executive Committee: Biosynex
| Manager | Title | Age | Since |
|---|---|---|---|
Larry Abensur
CEO | Chief Executive Officer | 71 | 2015-06-23 |
Thierry Paper
CTO | Chief Tech/Sci/R&D Officer | 63 | 2014-12-31 |
Oren Bitton
PRN | Corporate Officer/Principal | - | - |
Composition of the Board of Directors: Biosynex
| Director | Title | Age | Since |
|---|---|---|---|
Thierry Paper
BRD | Director/Board Member | 63 | 2015-06-23 |
Thomas Lamy
BRD | Director/Board Member | - | 2015-06-23 |
Larry Abensur
CHM | Chairman | 71 | 2015-06-23 |
Elie Fraenckel
BRD | Director/Board Member | - | 2012-10-31 |
Brigitte Geny
BRD | Director/Board Member | - | 2024-06-06 |
Diane Abensur
BRD | Director/Board Member | - | 2024-06-06 |
Company details: Biosynex
Biosynex SA
22, boulevard Sebastien Brant
67400, Illkirch-Graffenstaden
+33 3 88 78 78 87
http://www.biosynex.com
Group companies: Biosynex
| Name | Category and Sector |
|---|---|
Biosynex Swiss SA |
Diagnostic & Testing Substances
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.48% | -10.32% | +21.57% | -91.47% | 17.39M | ||
| -2.17% | -4.33% | -27.56% | -0.17% | 167B | ||
| +0.17% | -2.34% | -8.83% | +10.31% | 111B | ||
| -0.88% | +1.19% | -25.04% | -0.11% | 105B | ||
| +0.76% | +1.29% | -47.98% | -10.94% | 74.82B | ||
| +3.17% | -0.03% | -0.64% | +72.13% | 59.11B | ||
| -0.86% | +2.96% | +13.57% | +59.50% | 51.8B | ||
| -0.52% | -0.65% | -6.74% | -31.12% | 48.5B | ||
| -0.85% | +0.85% | -16.51% | +18.41% | 40.79B | ||
| -0.07% | -1.42% | +30.49% | -7.58% | 32.54B | ||
| Average | +0.16% | -0.77% | -6.77% | +1.89% | 69.02B | |
| Weighted average by Cap. | +0.35% | -0.91% | -16.14% | +9.59% |
- Stock Market
- Stocks
- ALBIO Stock
- Company Biosynex
Select your edition
All financial news and data tailored to specific country editions

















